MK-886 - A NOVEL MECHANISM, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR

被引:0
|
作者
GILLARD, JW
MORTON, HE
DIXON, R
EVANS, J
FORTIN, R
GAUTHIER, JY
MACFARLANE, C
MILLER, D
ROUZER, C
VICKERS, P
FORDHUTCHINSON, AW
机构
[1] MERCK FROSST CTR THERAPEUT RES,POINTE CLAIRE H9R 4PB,QUEBEC,CANADA
[2] MERCK & CO INC,RAHWAY,NJ 07065
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:150 / MEDI
相关论文
共 50 条
  • [21] PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF A NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, MK-0591, IN HEALTHY-VOLUNTEERS
    UEMATSU, T
    KANAMARU, M
    KOSUGE, K
    HARA, K
    UCHIYAMA, N
    TAKENAGA, N
    TANAKA, W
    FRIEDMAN, BS
    NAKASHIMA, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (01) : 59 - 66
  • [22] MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation
    Koeberle, Andreas
    Siemoneit, Ulf
    Northoff, Hinnak
    Hofmann, Bettina
    Schneider, Gisbert
    Werz, Oliver
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 608 (1-3) : 84 - 90
  • [23] MK886, A POTENT AND SPECIFIC LEUKOTRIENE BIOSYNTHESIS INHIBITOR BLOCKS AND REVERSES THE MEMBRANE ASSOCIATION OF 5-LIPOXYGENASE IN IONOPHORE-CHALLENGED LEUKOCYTES
    ROUZER, CA
    FORDHUTCHINSON, AW
    MORTON, HE
    GILLARD, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (03) : 1436 - 1442
  • [24] INHIBITION OF LEUKOTRIENE BIOSYNTHESIS AND POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONS BY ORALLY ACTIVE QUINOLYLMETHOXYPHENYLAMINES
    KIRSTEIN, D
    THOMSEN, MK
    AHNFELTRONNE, I
    PHARMACOLOGY & TOXICOLOGY, 1991, 68 (02): : 125 - 130
  • [25] Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats
    Stanke-Labesque, F
    Hardy, G
    Caron, F
    Cracowski, JL
    Bessard, G
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) : 186 - 194
  • [26] ANTIASTHMATIC EFFECTS OF A LEUKOTRIENE BIOSYNTHESIS INHIBITOR (MK-0591) IN ALLERGIC DOGS
    BECKER, AB
    BLACK, C
    LILLEY, MK
    BAJWA, K
    FORDHUTCHINSON, AW
    SIMONS, FER
    TAGARI, P
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 78 (02) : 615 - 622
  • [27] A novel orally active inhibitor of HLE
    Varga, M
    Kapui, Z
    Bátori, S
    Nagy, LT
    Vasvári-Debreczy, L
    Mikus, E
    Urbán-Szabó, K
    Arányi, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (04) : 421 - 425
  • [28] 5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo
    Imbesi, Marta
    Zavoreo, Iris
    Uz, Tolga
    Sharma, Rajiv P.
    Dimitrijevic, Nikola
    Manev, Hari
    Manev, Radmila
    BRAIN RESEARCH, 2007, 1147 : 148 - 153
  • [29] INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH A-53612, A SELECTIVE AND ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE (5-LO)
    ALBERT, DH
    DYER, R
    YOUNG, PR
    BARLOW, J
    BORNEMEIER, D
    BOUSKA, J
    ROBERTS, E
    SONSALLA, J
    BROOKS, DW
    CARTER, GW
    FASEB JOURNAL, 1988, 2 (04): : A369 - A369
  • [30] Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
    Uz, Tolga
    Dimitrijevic, Nikola
    Imbesi, Marta
    Manev, Hari
    Manev, Radmila
    NEUROSCIENCE LETTERS, 2008, 436 (02) : 269 - 272